Astrazeneca Share Discussion Threads

[blackhorse23] 09/1/2024 11:01

are they buying APH ??

[philanderer] 03/1/2024 11:52

Jefferies cuts AstraZeneca to 'hold' (buy) - price target 11,000 (12,500) pence

[philanderer] 02/1/2024 18:46

January 02, 2024 at 08:55 am

JP Morgan analyst James Gordon maintains his Buy rating on the stock. The target price remains unchanged at GBX 13000.

[philanderer] 02/1/2024 11:36

On the FTSE 100, AstraZeneca was down 0.3%.

The Cambridge-based pharmaceutical firm said its and Sanofi’s long-acting monoclonal antibody treatment Beyfortus has been approved in China for the prevention of respiratory syncytial virus lower respiratory tract infection in neonates and infants.

AstraZeneca said the approval by China’s National Medical Products Administration is based on three ‘pivotal’ late-stage clinical trials and an ‘extensive’ local clinical development programme. It is anticipated to be available during the upcoming 2024/25 RSV season.

Beyfortus was approved in the EU in October 2022 and received approval by the US Food & Drug Administration in July 2023 following the unanimous recommendation by the Antimicrobial Drugs Advisory Committee in June 2023.

AstraZeneca said regulatory applications are currently under review in Japan and ‘several other countries’.

[turvart] 22/12/2023 07:22

Great RNS!! should see at least 10700 today and that is still under the 200 DMA.

[hopefuldave] 16/12/2023 16:53

A Astra Covid vaccine is causing serious illness in some cases. Is this bad news a cause for concern?, anybody know?

[smcni1968] 15/12/2023 15:44

Hopefully a better year for the share price in 2024.

[philanderer] 15/12/2023 14:41

Telegraph tip

Questor Wealth Preserver: as one of our holdings looks likely to be taken over, we are replacing it with a high-quality pharmaceutical stock





Article:

[philanderer] 14/12/2023 16:43

Non Exec director buy


487 at £101.8956

[dudishes] 08/12/2023 13:48

9976 in, seems a good time short bet to me?

11K?

[tmas] 07/12/2023 17:21

Was expecting they would be taking over LumiraDx LMDX after partnership deal
hxxps://www.pharmashots.com/16262/lumiradx-collaborates-with-astrazeneca-and-everton-to-establish
Turns out it may be Roche RHHBY

[turvart] 05/12/2023 17:50

AZN now well below the 200 & 50 day moving average, the 200 day MA is approx 11000 area so this is a steal IMO with all the future developments in phase 11 & 111 trials. One aspect I also like is the fact AZN do not stand still and get complacent the company is always striving to get bigger and make regular acquisitions.

AZN was my very first stock I purchased when I was a complete newbie back in 2001 and I paid £17.50 a share back then, look at the growth of this immense stock of which I'm sure will get to £130 by the end of 2024 IMO, AZN was in my portfolio in 2001 at 1750 and still are and has been my best performing stock, just wished I'd have bought more and left them alone re-investing the dividends along the way.

Strong buy IMO.

[philanderer] 05/12/2023 10:33

JPMorgan cuts AstraZeneca price target to 13,000 (14,000) pence - 'overweight'

[1knocker] 27/11/2023 23:09

I have placed a limit order to buy at 95. I may pull it in favour of something paying a better dividend. there is plenty to chose from at present. The important thing in this market is not to chase. Let the price come to us.

[philanderer] 27/11/2023 19:22

Sharecast market report..

"....Pharmaceutical giant AstraZeneca was off 1.73% after a broker note from Jefferies, which lowered its price target on the shares from 13,000p to 12,500p."


edit:

AstraZeneca sank after the City broker Jefferies stressed it needed to provide more clarity on its forecasts and cut its target price to 12500p from 13000p.

DMail market report

[philanderer] 27/11/2023 16:20

One week on and it's really struggling again to hold £100 level.

[philanderer] 22/11/2023 14:19

Questor tip 'Buy'


'Elephants don’t gallop – except for AstraZeneca'

Questor share tip: the company’s growth rate and valuation suggest further capital gains are ahead

[f880gna] 20/11/2023 22:48

PER still looks very toppy, a lot of scope for disappointment there.

[philanderer] 20/11/2023 12:27

Struggling to keep above £100

[mr euro] 17/11/2023 18:41

Greg B. Yes. They will divest China but whether that is a sale or separate listing, I don't know.

AZ China is 15% of AZ TO so its relevant.

[smcni1968] 17/11/2023 11:24

Fading already- maybe 2024 will be a better year. I'm sure part of the problem is that the incremental $$$$ is going into Eli Lilly and Novo Nordisk so Astra and others are being ignored

[philanderer] 17/11/2023 10:49

Some good news...

In London’s FTSE 100, AstraZeneca rose 1.5%.

The pharmaceutical firm said its Truqap treatment for patients with advanced hormone receptor positive breast cancer, in combination with Faslodex, has been approved by the US Food & Drug Administration.

This follows the results from its CapItello-291 phase 3 trial published earlier this year, which showed reduced risk of disease progression or death by 50% compared to Faslodex alone.

[gregb] 17/11/2023 08:24

Do you have any more up to date info?

[mr euro] 17/11/2023 07:29

I don't own AZ so have no interest.

hxxps://www.fiercepharma.com/pharma/misinformation-astrazenecas-china-head-refutes-spinoff-report

Not sure how a sale would effect the share price, be it a sale or standalone listing out of HK? One would assume this would be positive.